Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Parkinson's Disease (PD) Drugs industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
- Dopamine Agonist
- Monoamine Oxidase Inhibitors
- Acetylcholinesterase Inhibitors
- Glutamate Inhibitors
Market Segment by Product Application
- Hospital
- Family
Finally, the report provides detailed profile and data information analysis of leading company.
- Boehringer Ingelheim
- Biogen
- Teva Pharmaceutical Industries
- GlaxoSmithKline
- Addex Therapeutics
- Novartis
- Eli Lilly
- Abital Pharma
- AbbVie
- Eisai
- Otsuka Pharmaceutical
- F. Hoffmann-La Roche
- Pfizer
- Kyowa Hakko Kirin
- H. Lundbeck
- Impax Laboratories
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
- 1.To study and analyze the global Parkinson's Disease (PD) Drugs consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
- 2.To understand the structure of Parkinson's Disease (PD) Drugs market by identifying its various subsegments.
- 3.Focuses on the key global Parkinson's Disease (PD) Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
- 4.To analyze the Parkinson's Disease (PD) Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
- 5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- 6.To project the consumption of Parkinson's Disease (PD) Drugs submarkets, with respect to key regions (along with their respective key countries).
- 7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- 8.To strategically profile the key players and comprehensively analyze their growth strategies.
Global Parkinson's Disease (PD) Drugs Professional Survey Report 2021, Forecast to 2026
Table of Contents
Global Parkinson's Disease (PD) Drugs Professional Survey Report Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Parkinson's Disease (PD) Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Parkinson's Disease (PD) Drugs Segment by Type
2.1.1 Dopamine Agonist
2.1.2 Monoamine Oxidase Inhibitors
2.1.3 Acetylcholinesterase Inhibitors
2.1.4 Glutamate Inhibitors
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Family
2.3 Global Parkinson's Disease (PD) Drugs Market Comparison by Regions (2016-2026)
2.3.1 Global Parkinson's Disease (PD) Drugs Market Size (2016-2026)
2.3.2 North America Parkinson's Disease (PD) Drugs Status and Prospect (2016-2026)
2.3.3 Europe Parkinson's Disease (PD) Drugs Status and Prospect (2016-2026)
2.3.4 Asia-pacific Parkinson's Disease (PD) Drugs Status and Prospect (2016-2026)
2.3.5 South America Parkinson's Disease (PD) Drugs Status and Prospect (2016-2026)
2.3.6 Middle East & Africa Parkinson's Disease (PD) Drugs Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Parkinson's Disease (PD) Drugs Industry Impact
2.5.1 Parkinson's Disease (PD) Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Parkinson's Disease (PD) Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Parkinson's Disease (PD) Drugs Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Parkinson's Disease (PD) Drugs Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Parkinson's Disease (PD) Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Parkinson's Disease (PD) Drugs Manufacturer Market Share
3.5 Top 10 Parkinson's Disease (PD) Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
3.7 Key Manufacturers Parkinson's Disease (PD) Drugs Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Parkinson's Disease (PD) Drugs Industry Key Manufacturers
4.1 Boehringer Ingelheim
4.1.1 Company Details
4.1.2 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Boehringer Ingelheim News
4.2 Biogen
4.2.1 Company Details
4.2.2 Biogen Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.2.3 Biogen Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Biogen News
4.3 Teva Pharmaceutical Industries
4.3.1 Company Details
4.3.2 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.3.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Teva Pharmaceutical Industries News
4.4 GlaxoSmithKline
4.4.1 Company Details
4.4.2 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.4.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 GlaxoSmithKline News
4.5 Addex Therapeutics
4.5.1 Company Details
4.5.2 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.5.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Addex Therapeutics News
4.6 Novartis
4.6.1 Company Details
4.6.2 Novartis Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.6.3 Novartis Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Novartis News
4.7 Eli Lilly
4.7.1 Company Details
4.7.2 Eli Lilly Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.7.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.5 Eli Lilly News
4.8 Abital Pharma
4.8.1 Company Details
4.8.2 Abital Pharma Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.8.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 Abital Pharma News
4.9 AbbVie
4.9.1 Company Details
4.9.2 AbbVie Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.9.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 AbbVie News
4.10 Eisai
4.10.1 Company Details
4.10.2 Eisai Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.10.3 Eisai Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.10.4 Main Business Overview
4.10.5 Eisai News
4.11 Otsuka Pharmaceutical
4.11.1 Company Details
4.11.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.11.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.11.4 Main Business Overview
4.11.5 Otsuka Pharmaceutical News
4.12 F. Hoffmann-La Roche
4.12.1 Company Details
4.12.2 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.12.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.12.4 Main Business Overview
4.12.5 F. Hoffmann-La Roche News
4.13 Pfizer
4.13.1 Company Details
4.13.2 Pfizer Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.13.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.13.4 Main Business Overview
4.13.5 Pfizer News
4.14 Kyowa Hakko Kirin
4.14.1 Company Details
4.14.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.14.4 Main Business Overview
4.14.5 Kyowa Hakko Kirin News
4.15 H. Lundbeck
4.15.1 Company Details
4.15.2 H. Lundbeck Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.15.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.15.4 Main Business Overview
4.15.5 H. Lundbeck News
4.16 Impax Laboratories
4.16.1 Company Details
4.16.2 Impax Laboratories Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
4.16.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.16.4 Main Business Overview
4.16.5 Impax Laboratories News
5 Global Parkinson's Disease (PD) Drugs Sales Categorized by Regions
5.1 Global Parkinson's Disease (PD) Drugs Revenue, Sales and Market Share by Regions
5.1.1 Global Parkinson's Disease (PD) Drugs Sales and Market Share by Regions (2016-2021)
5.1.2 Global Parkinson's Disease (PD) Drugs Revenue and Market Share by Regions (2016-2021)
5.2 North America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
5.3 Europe Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
5.4 Asia-pacific Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
5.5 South America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
5.6 Middle East & Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
6 North America Parkinson's Disease (PD) Drugs Market Size Categorized by Countries
6.1 North America Parkinson's Disease (PD) Drugs Sales, Revenue and Market Share by Countries
6.1.1 North America Parkinson's Disease (PD) Drugs Sales (Volume) by Countries (2016-2021)
6.1.2 North America Parkinson's Disease (PD) Drugs Revenue by Countries (2016-2021)
6.1.3 United States Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
6.1.4 Canada Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
6.1.5 Mexico Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
6.2 North America Parkinson's Disease (PD) Drugs Revenue (Value) by Manufacturers
6.3 North America Parkinson's Disease (PD) Drugs Sales and Market Share by Type (2016-2021)
6.4 North America Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
7 Europe Parkinson's Disease (PD) Drugs Market Size Categorized by Countries
7.1 Europe Parkinson's Disease (PD) Drugs Sales, Revenue and Market Share by Countries
7.1.1 Europe Parkinson's Disease (PD) Drugs Sales (Volume) by Countries (2016-2021)
7.1.2 Europe Parkinson's Disease (PD) Drugs Revenue by Countries (2016-2021)
7.1.3 Germany Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
7.1.4 UK Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
7.1.5 France Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
7.1.6 Russia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
7.1.7 Italy Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
7.1.8 Spain Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
7.2 Europe Parkinson's Disease (PD) Drugs Revenue (Value) by Manufacturers
7.3 Europe Parkinson's Disease (PD) Drugs Sales and Market Share by Type (2016-2021)
7.4 Europe Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
8 Asia-Pacific Parkinson's Disease (PD) Drugs Market Size Categorized by Countries
8.1 Asia-pacific Parkinson's Disease (PD) Drugs Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Parkinson's Disease (PD) Drugs Sales (Volume) by Countries (2016-2021)
8.1.2 Asia-pacific Parkinson's Disease (PD) Drugs Revenue by Countries (2016-2021)
8.1.3 China Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
8.1.4 South Korea Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
8.1.5 Japan Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
8.1.6 Australia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
8.1.7 India Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
8.1.8 Southeast Asia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
8.2 Asia-pacific Parkinson's Disease (PD) Drugs Revenue (Value) by Manufacturers
8.3 Asia-pacific Parkinson's Disease (PD) Drugs Sales and Market Share by Type (2016-2021)
8.4 Asia-pacific Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
9 South America Parkinson's Disease (PD) Drugs Market Size Categorized by Countries
9.1 South America Parkinson's Disease (PD) Drugs Sales, Revenue and Market Share by Countries
9.1.1 South America Parkinson's Disease (PD) Drugs Sales (Volume) by Countries (2016-2021)
9.1.2 South America Parkinson's Disease (PD) Drugs Revenue by Countries (2016-2021)
9.1.3 Brazil Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
9.2 South America Parkinson's Disease (PD) Drugs Sales and Market Share by Type (2016-2021)
9.3 South America Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
10 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size Categorized by Countries
10.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales (Volume) by Countries (2016-2021)
10.1.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Countries (2016-2021)
10.1.3 GCC Countries Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
10.1.4 Turkey Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
10.1.5 Egypt Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
10.1.6 South America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
10.2 Middle East and Africa Parkinson's Disease (PD) Drugs Sales and Market Share by Type
10.3 Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
11 Global Parkinson's Disease (PD) Drugs Market Segment by Type
11.1 Global Parkinson's Disease (PD) Drugs Revenue, Sales and Market Share by Type (2016-2021)
11.1.1 Global Parkinson's Disease (PD) Drugs Sales and Market Share by Type (2016-2021)
11.1.2 Global Parkinson's Disease (PD) Drugs Revenue and Market Share by Type (2016-2021)
11.2 Dopamine Agonist Sales Growth Rate and Price
11.2.1 Global Dopamine Agonist Sales Growth Rate (2016-2021)
11.2.2 Global Dopamine Agonist Price (2016-2021)
11.3 Monoamine Oxidase Inhibitors Sales Growth Rate and Price
11.3.1 Global Monoamine Oxidase Inhibitors Sales Growth Rate (2016-2021)
11.3.2 Global Monoamine Oxidase Inhibitors Price (2016-2021)
11.4 Acetylcholinesterase Inhibitors Sales Growth Rate and Price
11.4.1 Global Acetylcholinesterase Inhibitors Sales Growth Rate (2016-2021)
11.4.2 Global Acetylcholinesterase Inhibitors Price (2016-2021)
11.5.1 Global Glutamate Inhibitors Sales Growth Rate (2016-2021)
11.5.2 Global Glutamate Inhibitors Price (2016-2021)
12 Global Parkinson's Disease (PD) Drugs Market Segment by Application
12.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
12.2 Hospital Sales Growth Rate (2016-2021)
12.3 Family Sales Growth Rate (2016-2021)
13 Global Parkinson's Disease (PD) Drugs Market Forecast
13.1 Global Parkinson's Disease (PD) Drugs Revenue, Sales and Growth Rate (2021-2026)
13.2 Parkinson's Disease (PD) Drugs Market Forecast by Regions (2021-2026)
13.2.1 North America Parkinson's Disease (PD) Drugs Market Forecast (2021-2026)
13.2.2 Europe Parkinson's Disease (PD) Drugs Market Forecast (2021-2026)
13.2.3 Asia-Pacific Parkinson's Disease (PD) Drugs Market Forecast (2021-2026)
13.2.4 South America Parkinson's Disease (PD) Drugs Market Forecast (2021-2026)
13.2.5 Middle East & Africa Parkinson's Disease (PD) Drugs Market Forecast (2021-2026)
13.3 Parkinson's Disease (PD) Drugs Market Forecast by Type (2021-2026)
13.3.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2021-2026)
13.3.2 Global Parkinson's Disease (PD) Drugs Market Share Forecast by Type (2021-2026)
13.4 Parkinson's Disease (PD) Drugs Market Forecast by Application (2021-2026)
13.4.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2021-2026)
13.4.2 Global Parkinson's Disease (PD) Drugs Market Share Forecast by Application (2021-2026)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Parkinson's Disease (PD) Drugs Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Parkinson's Disease (PD) Drugs Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Parkinson's Disease (PD) Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Parkinson's Disease (PD) Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Parkinson's Disease (PD) Drugs Market Size by Type
Figure Global Market Share of Parkinson's Disease (PD) Drugs by Type in 2020
Figure Dopamine Agonist Picture
Figure Monoamine Oxidase Inhibitors Picture
Figure Acetylcholinesterase Inhibitors Picture
Figure Glutamate Inhibitors Picture
Table Global Parkinson's Disease (PD) Drugs Market Size (Volume) by Application
Figure Hospital Picture
Figure Family Picture
Table Global Parkinson's Disease (PD) Drugs Comparison by Regions (M USD) 2016-2026
Figure Global Parkinson's Disease (PD) Drugs Market Size (Million US$) (2016-2026)
Figure North America Parkinson's Disease (PD) Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Parkinson's Disease (PD) Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure Asia-pacific Parkinson's Disease (PD) Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure South America Parkinson's Disease (PD) Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure Middle East & Africa Parkinson's Disease (PD) Drugs Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Parkinson's Disease (PD) Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Parkinson's Disease (PD) Drugs Sales by Manufacturer (2016-2021)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturer in 2020
Table Global Parkinson's Disease (PD) Drugs Revenue by Manufacturer (2016-2021)
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturer in 2020
Table Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Parkinson's Disease (PD) Drugs Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Parkinson's Disease (PD) Drugs Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
Table Key Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table Mergers & Acquisitions Planning
Table Boehringer Ingelheim Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Boehringer Ingelheim
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2016-2021
Table Boehringer Ingelheim Main Business
Table Boehringer Ingelheim Recent Development
Table Biogen Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Biogen
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biogen 2016-2021
Table Biogen Main Business
Table Biogen Recent Development
Table Teva Pharmaceutical Industries Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Teva Pharmaceutical Industries
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Teva Pharmaceutical Industries 2016-2021
Table Teva Pharmaceutical Industries Main Business
Table Teva Pharmaceutical Industries Recent Development
Table GlaxoSmithKline Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of GlaxoSmithKline
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of GlaxoSmithKline 2016-2021
Table GlaxoSmithKline Main Business
Table GlaxoSmithKline Recent Development
Table Addex Therapeutics Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Addex Therapeutics
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Addex Therapeutics 2016-2021
Table Addex Therapeutics Main Business
Table Addex Therapeutics Recent Development
Table Novartis Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Novartis
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2016-2021
Table Novartis Main Business
Table Novartis Recent Development
Table Eli Lilly Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Eli Lilly
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly 2016-2021
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Abital Pharma Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Abital Pharma
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Abital Pharma 2016-2021
Table Abital Pharma Main Business
Table Abital Pharma Recent Development
Table AbbVie Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of AbbVie
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AbbVie 2016-2021
Table AbbVie Main Business
Table AbbVie Recent Development
Table Eisai Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Eisai
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Eisai 2016-2021
Table Eisai Main Business
Table Eisai Recent Development
Table Otsuka Pharmaceutical Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Otsuka Pharmaceutical
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Otsuka Pharmaceutical 2016-2021
Table Otsuka Pharmaceutical Main Business
Table Otsuka Pharmaceutical Recent Development
Table F. Hoffmann-La Roche Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of F. Hoffmann-La Roche
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of F. Hoffmann-La Roche 2016-2021
Table F. Hoffmann-La Roche Main Business
Table F. Hoffmann-La Roche Recent Development
Table Pfizer Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Pfizer
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2016-2021
Table Pfizer Main Business
Table Pfizer Recent Development
Table Kyowa Hakko Kirin Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Kyowa Hakko Kirin
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Kyowa Hakko Kirin 2016-2021
Table Kyowa Hakko Kirin Main Business
Table Kyowa Hakko Kirin Recent Development
Table H. Lundbeck Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of H. Lundbeck
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of H. Lundbeck 2016-2021
Table H. Lundbeck Main Business
Table H. Lundbeck Recent Development
Table Impax Laboratories Company Profile
Table Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification of Impax Laboratories
Table Parkinson's Disease (PD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Impax Laboratories 2016-2021
Table Impax Laboratories Main Business
Table Impax Laboratories Recent Development
Figure Global Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure Global Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2016-2021)
Table Global Parkinson's Disease (PD) Drugs Sales by Regions (2016-2021)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions in 2020
Table Global Parkinson's Disease (PD) Drugs Revenue by Regions (2016-2021)
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions in 2020
Figure North America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure Europe Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure Asia-pacific Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure South America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure Middle East & Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure North America Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2016-2021)
Table North America Parkinson's Disease (PD) Drugs Sales (Volume) by Countries (2016-2021)
Table North America Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2016-2021)
Figure North America Parkinson's Disease (PD) Drugs Sales Market Share by Countries in 2020
Table North America Parkinson's Disease (PD) Drugs Revenue by Countries (2016-2021)
Table North America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2016-2021)
Figure North America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2020
Figure United States Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure Canada Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure Mexico Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Table North America Parkinson's Disease (PD) Drugs Revenue by Manufacturer (2020)
Figure North America Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturer in 2020
Table North America Parkinson's Disease (PD) Drugs Sales by Type (2016-2021)
Table North America Parkinson's Disease (PD) Drugs Sales Share by Type (2016-2021)
Table North America Parkinson's Disease (PD) Drugs Sales by Application (2016-2021)
Table North America Parkinson's Disease (PD) Drugs Sales Share by Application (2016-2021)
Figure Europe Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2016-2021)
Table Europe Parkinson's Disease (PD) Drugs Sales (Volume) by Countries (2016-2021)
Table Europe Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2016-2021)
Figure Europe Parkinson's Disease (PD) Drugs Sales Market Share by Countries in 2020
Table Europe Parkinson's Disease (PD) Drugs Revenue by Countries (2016-2021)
Table Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2016-2021)
Figure Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2020
Figure Germany Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure UK Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure France Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure Russia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure Italy Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure Spain Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Table Europe Parkinson's Disease (PD) Drugs Revenue by Manufacturer (2020)
Figure Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturer in 2020
Table Europe Parkinson's Disease (PD) Drugs Sales by Type (2016-2021)
Table Europe Parkinson's Disease (PD) Drugs Sales Share by Type (2016-2021)
Table Europe Parkinson's Disease (PD) Drugs Sales by Application (2016-2021)
Table Europe Parkinson's Disease (PD) Drugs Sales Share by Application (2016-2021)
Figure Asia-pacific Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2016-2021)
Table Asia-pacific Parkinson's Disease (PD) Drugs Sales (Volume) by Countries (2016-2021)
Table Asia-pacific Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2016-2021)
Figure Asia-pacific Parkinson's Disease (PD) Drugs Sales Market Share by Countries in 2020
Table Asia-pacific Parkinson's Disease (PD) Drugs Revenue by Countries (2016-2021)
Table Asia-pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2016-2021)
Figure Asia-pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2020
Figure China Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure South Korea Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure Japan Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure Australia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure India Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Figure Southeast Asia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Table Asia-pacific Parkinson's Disease (PD) Drugs Revenue by Manufacturer (2020)
Figure Asia-pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturer in 2020
Table Asia-pacific Parkinson's Disease (PD) Drugs Sales by Type (2016-2021)
Table Asia-pacific Parkinson's Disease (PD) Drugs Sales Share by Type (2016-2021)
Table Asia-pacific Parkinson's Disease (PD) Drugs Sales by Application (2016-2021)
Table Asia-pacific Parkinson's Disease (PD) Drugs Sales Share by Application (2016-2021)
Figure South America Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2016-2021)
Table South America Parkinson's Disease (PD) Drugs Sales (Volume) by Countries (2016-2021)
Table South America Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2016-2021)
Figure South America Parkinson's Disease (PD) Drugs Sales Market Share by Countries in 2019
Table South America Parkinson's Disease (PD) Drugs Revenue by Countries (2016-2021)
Table South America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2016-2021)
Figure South America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2019
Figure Brazil Parkinson's Disease (PD) Drugs Sales and Growth Rate (2016-2021)
Table South America Par
Global Parkinson's Disease Therapeutics Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 99
Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......
Global Amantadine Hydrochloride Market Insights, Forecast to 2029
Published: 29-Aug-2023 Price: US 4900 Onwards Pages: 109
Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder.
The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......
Global Rasagiline Tablet Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 107
Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.
The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......
Global Parkinsons Disease Drug Market Insights, Forecast to 2029
Published: 02-Aug-2023 Price: US 4900 Onwards Pages: 113
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
Global P......
Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028
Published: 20-Mar-2023 Price: US 2680 Onwards Pages: 137
Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028
Published: 20-Mar-2023 Price: US 3280 Onwards Pages: 109
Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
Global Amantadine Hydrochloride Market Research Report 2023
Published: 09-Mar-2023 Price: US 2900 Onwards Pages: 98
Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder.
Highlights
The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Amantadine hydrochloride is clinically effective......
Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028
Published: 21-Feb-2023 Price: US 3280 Onwards Pages: 133
Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
Published: 21-Feb-2023 Price: US 2680 Onwards Pages: 159
Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
